Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies	Fanconi anemia complementation group D1, Fanconi anemia complementation group N, microphthalmia, syndromic 9	Recruiting	Phase 1	2026-09-02		NCT06458712

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Duke Street Bio Ltd	1

21 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Centrum Terapii Wspolczesnej	Lodz	Poland	3
Clinica Universidad de Navarra - Madrid	Madrid	Spain	13
Clinica Universidad de Navarra - Pamplona	Pamplona	Spain	11
Hospital 12 de Octubre	Madrid	Spain	13
Hospital Universitari Vall d'Hebron	Barcelona	Spain	45
Hospital Universitario Reina Sofía	Córdoba	Spain	18
Hospital Universitario Virgen de La Victoria	Málaga	Spain	79
Institut Bergonie	Bordeaux	France	23
Institut Godinot	Reims	France	12
Instituto Valenciano de Oncologia	Valencia	Spain	20
Orszagos Onkologiai Intezet	Budapest	Hungary	20
Polish Mother's Memorial Hospital - Research Institute	Lodz	Poland	1
START Barcelona, CIOCC, Hospital Universitario Nou Delfos	Barcelona	Spain	1
START La Rioja, Hospital Universitario San Pedro	Logroño	Spain	1
START Madrid-CIOCC, Hospital Universitario HM Sanchinarro	Madrid	Spain	1
The University of Texas M. D. Anderson Cancer Center	Houston	United States	88
Tisch Cancer Institute Icahn School of Medicine at Mount Sinai	New York	United States	1
UC Davis Medical Centre	Sacramento	United States	1
Universitary Hospital Virgen del Rocio	Seville	Spain	1
Uniwersytecki Szpital Kliniczny w Poznaniu	Poznan	Poland	22
Yale Cancer Center - Yale New Haven Hospital	New Haven	United States	1

Clinical trials